Aurinia [AUPH] vs Vericel [VCEL] Detailed Stock Comparison
Aurinia
NASDAQ
Loading...
Vericel
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Aurinia wins in 16 metrics, Vericel wins in 2 metrics, with 0 ties. Aurinia appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Aurinia | Vericel | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.09 | 255.21 | Aurinia |
| Price-to-Book Ratio | 4.78 | 5.87 | Aurinia |
| Debt-to-Equity Ratio | 24.41 | 32.74 | Aurinia |
| PEG Ratio | 22.37 | 74.44 | Aurinia |
| EV/EBITDA | 16.43 | 190.23 | Aurinia |
| Profit Margin (TTM) | 23.31% | 2.85% | Aurinia |
| Operating Margin (TTM) | 28.85% | -3.21% | Aurinia |
| EBITDA Margin (TTM) | 28.85% | N/A | N/A |
| Return on Equity | 17.33% | 2.59% | Aurinia |
| Return on Assets (TTM) | 7.69% | 0.18% | Aurinia |
| Free Cash Flow (TTM) | $44.11M | $-5.81M | Aurinia |
| 1-Year Return | 81.51% | -24.87% | Aurinia |
| Price-to-Sales Ratio (TTM) | 6.11 | 7.24 | Aurinia |
| Enterprise Value | $1.36B | $1.81B | Vericel |
| EV/Revenue Ratio | 5.22 | 7.26 | Aurinia |
| Gross Profit Margin (TTM) | 89.84% | 73.71% | Aurinia |
| Revenue per Share (TTM) | $2 | $5 | Vericel |
| Earnings per Share (Diluted) | $0.43 | $0.14 | Aurinia |
| Beta (Stock Volatility) | 1.24 | 1.27 | Aurinia |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Aurinia vs Vericel Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Aurinia | 1.57% | 0.00% | 38.18% | 48.37% | 52.42% | 39.91% |
| Vericel | 4.49% | 2.07% | -2.50% | -10.51% | -29.24% | -32.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Aurinia | 81.51% | 58.94% | -10.89% | 304.95% | 228.95% | 228.95% |
| Vericel | -24.87% | 36.79% | 126.21% | 1,068.14% | 32.25% | -91.70% |
Performance & Financial Health Analysis: Aurinia vs Vericel
| Metric | AUPH | VCEL |
|---|---|---|
| Market Information | ||
| Market Cap | $1.59B | $1.80B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,119,340 | 456,322 |
| 90 Day Avg. Volume | 2,421,113 | 589,887 |
| Last Close | $12.27 | $37.03 |
| 52 Week Range | $6.42 - $12.53 | $33.09 - $63.00 |
| % from 52W High | -2.08% | -41.22% |
| All-Time High | $33.97 (Nov 01, 2021) | $1,590.00 (Sep 22, 1997) |
| % from All-Time High | -63.88% | -97.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.22% | 0.20% |
| Quarterly Earnings Growth | 28.80% | 0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.23% | 0.03% |
| Operating Margin (TTM) | 0.29% | -0.03% |
| Return on Equity (TTM) | 0.17% | 0.03% |
| Debt to Equity (MRQ) | 24.41 | 32.74 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.53 | $6.08 |
| Cash per Share (MRQ) | $2.39 | $2.32 |
| Operating Cash Flow (TTM) | $92.68M | $47.24M |
| Levered Free Cash Flow (TTM) | $59.60M | $-5,594,625 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Aurinia vs Vericel
| Metric | AUPH | VCEL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.09 | 255.21 |
| Forward P/E | 22.37 | 74.44 |
| PEG Ratio | 22.37 | 74.44 |
| Price to Sales (TTM) | 6.11 | 7.24 |
| Price to Book (MRQ) | 4.78 | 5.87 |
| Market Capitalization | ||
| Market Capitalization | $1.59B | $1.80B |
| Enterprise Value | $1.36B | $1.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.22 | 7.26 |
| Enterprise to EBITDA | 16.43 | 190.23 |
| Risk & Other Metrics | ||
| Beta | 1.24 | 1.27 |
| Book Value per Share (MRQ) | $2.53 | $6.08 |
Financial Statements Comparison: Aurinia vs Vericel
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AUPH | VCEL |
|---|---|---|
| Revenue/Sales | $62.47M | $52.60M |
| Cost of Goods Sold | $8.57M | $16.33M |
| Gross Profit | $53.89M | $36.27M |
| Research & Development | $5.74M | $7.26M |
| Operating Income (EBIT) | $23.38M | $-12.79M |
| EBITDA | $31.81M | $-8.41M |
| Pre-Tax Income | $24.35M | $-11.25M |
| Income Tax | $1.01M | N/A |
| Net Income (Profit) | $23.34M | $-11.25M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AUPH | VCEL |
|---|---|---|
| Cash & Equivalents | $66.43M | $73.49M |
| Total Current Assets | $405.76M | $197.64M |
| Total Current Liabilities | $68.41M | $39.45M |
| Long-Term Debt | $62.37M | $87.80M |
| Total Shareholders Equity | $350.19M | $295.49M |
| Retained Earnings | $-913.23M | $-404.06M |
| Property, Plant & Equipment | $87.58M | $68.72M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AUPH | VCEL |
|---|---|---|
| Operating Cash Flow | $19.52M | $12.44M |
| Capital Expenditures | $-17,000 | N/A |
| Free Cash Flow | $1.28M | $-7.61M |
| Debt Repayment | $-2.77M | N/A |
| Common Stock Repurchase | $-46.92M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AUPH | VCEL |
|---|---|---|
| Shares Short | 9.16M | 5.56M |
| Short Ratio | 4.41 | 9.32 |
| Short % of Float | 0.08% | 0.14% |
| Average Daily Volume (10 Day) | 2,119,340 | 456,322 |
| Average Daily Volume (90 Day) | 2,421,113 | 589,887 |
| Shares Outstanding | 140.88M | 49.63M |
| Float Shares | 128.06M | 49.90M |
| % Held by Insiders | 0.07% | 0.01% |
| % Held by Institutions | 0.45% | 1.11% |
Dividend Analysis & Yield Comparison: Aurinia vs Vericel
| Metric | AUPH | VCEL |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |